Agenus launches its Clinical Trial combination of its anti-CTLA4 (AGEN1884) and anti-PD1 (AGEN2034) antibodies Read more
AstraZeneca and Merck asserted the approval of LYNPARZA tablets for patients with Ovarian Cancer Read more
Concept Life Sciences partners with Alderley Analytical ensuring bioanalytical and DMPK study services Read more